| Trial name or title |
The Virtual Asthma Clinic |
| Methods |
Phase IV, prevention, randomised, single‐blind (subject), placebo control, parallel‐assignment efficacy study over 12 months |
| Participants |
Physician diagnosis of asthma, FEV1 of at least 50% of predicted at baseline, evidence of 12% increase in FEV1 following inhaled bronchodilator. Ages 18 to 70. |
| Interventions |
Standardised education to all participants, baseline pulmonary function tests and instructions on using a peak flow monitor. One arm will receive active therapy using the internet site or a placebo therapy using a web‐based intervention. The active website will monitor the intervention group participants' asthma profile daily, with access to a certified asthma educator. IF patients do not log on for 7 days with poor control or 14 days with good control they will receive a telephone call. |
| Outcomes |
The 15 D and AQLQ at baseline, 6 months and 12 months, spirometry at 12 months. Symptom surveys at log in by the intervention groups. |
| Starting date |
March 2005 |
| Contact information |
Mayers, University of Alberta Hospital, Edmonton, Alberta, Canada, T6G 2B7 |
| Notes |
15 D and AQLQ are questionnaires |
